Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Standalone and Consolidated Financial Results for the quarter ended June 30, 2023.07-08-2023
07-08-2023
Aarti Pharmalabs Ltd - 543748 - Audited Financial Results For The Quarter Ended June 30, 2023
Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023.05-08-2023
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting held on Saturday, August 05, 2023.05-08-2023
Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Audited Financial Results And Any Other Business Matter, If Required
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 ,inter alia, to consider and approve Audited Financial Results and any other Business Matter, if required.28-07-2023
Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2023.07-07-2023
Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of Closure of Trading Window.29-06-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith Analyst Presentation of the Company.26-06-2023
Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2023.29-05-2023
Aarti Pharmalabs Ltd - 543748 - Related Party Transactions For The Half Year Ended March 31, 2023.
Updated List of Related Party Transactions for the Half year ended March 31, 2023.15-05-2023
